Cardinal Health Inc
NYSE:CAH
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
53.3B USD |
Loading...
|
|
| US |
|
Mckesson Corp
NYSE:MCK
|
117.9B USD |
Loading...
|
|
| US |
|
Cencora Inc
NYSE:COR
|
70.6B USD |
Loading...
|
|
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
69.7B USD |
Loading...
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
34B AUD |
Loading...
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
9.4B USD |
Loading...
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.6B CNY |
Loading...
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63.1B CNY |
Loading...
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
67.3B HKD |
Loading...
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW |
Loading...
|
|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
7.1B USD |
Loading...
|
Market Distribution
| Min | -24 813% |
| 30th Percentile | 28.9% |
| Median | 43% |
| 70th Percentile | 60.5% |
| Max | 10 905 714.3% |
Other Profitability Ratios
Cardinal Health Inc
Glance View
Cardinal Health Inc., a formidable player in the healthcare sector, operates with the intricacy and precision of a well-orchestrated symphony. At its core, the company thrives on the distribution of pharmaceuticals and medical products, deftly weaving through the complexities of the healthcare supply chain. Cardinal Health serves as a lifeline connecting manufacturers on one end to healthcare providers and pharmacies on the other, ensuring that vital medications and supplies reach those in need efficiently. With a robust logistics network and sophisticated information systems, the company navigates a sprawling array of over 46,000 products, delivering them with diligence to hospitals, clinics, and retail pharmacies across the globe. In its pursuit of business ingenuity, Cardinal Health has expanded its horizons beyond distribution. The company ventures into the vibrant realm of medical and surgical products, offering an array of services that cater to clinical laboratories, ambulatory surgery centers, and more. This diversification not only amplifies its revenue streams but also aligns with its strategic goal of building a comprehensive healthcare ecosystem. Cardinal Health earns its income by capitalizing on a combination of service fees, margins from product sales, and a spectrum of value-added solutions. This intricate blend allows the company to maintain a competitive edge in an era where healthcare demands are ever-evolving and cost-efficiency is paramount. This finely tuned business model is what enables Cardinal Health to sustain its economic vitality and continue its transformative impact on healthcare delivery.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Cardinal Health Inc is 3.7%, which is above its 3-year median of 3.4%.
Over the last 3 years, Cardinal Health Inc’s Gross Margin has increased from 3.4% to 3.7%. During this period, it reached a low of 3.3% on Jun 30, 2024 and a high of 3.7% on Jan 1, 2026.